B. Riley Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.21M Sell
90,498
-7,592
-8% -$199K 0.12% 169
2026
Q1
$2.72M Sell
98,090
-4,326
-4% -$115K 0.17% 129
2025
Q4
$2.55M Sell
102,416
-15,404
-13% -$388K 0.12% 175
2025
Q3
$3M Sell
117,820
-29,411
-20% -$726K 0.14% 148
2025
Q2
$3.57M Buy
+147,231
New +$3.43M 0.17% 127
2024
Q4
$6.62M Sell
249,606
-51,067
-17% -$1.39M 0.22% 103
2024
Q3
$8.63M Sell
300,673
-64,478
-18% -$1.88M 0.24% 87
2024
Q2
$10.2M Buy
365,151
+37,455
+11% +$1.03M 0.26% 80
2024
Q1
$10.9M Buy
327,696
+49,129
+18% +$1.36M 0.29% 71
2023
Q4
$8.02M Sell
278,567
-49,129
-15% -$1.49M 0.22% 101
2023
Q3
$10.9M Sell
327,696
-1,078
-0.3% -$38.1K 0.29% 71
2023
Q2
$12.1M Sell
328,774
-19,825
-6% -$772K 0.27% 78
2023
Q1
$14.2M Buy
348,599
+2,354
+0.7% +$102K 0.38% 53
2022
Q4
$17.7M Buy
346,245
+9,214
+3% +$442K 0.5% 40
2022
Q3
$14.8M Buy
337,031
+141,534
+72% +$6.88M 0.45% 45
2022
Q2
$10.3M Sell
195,497
-22,867
-10% -$1.17M 0.43% 49
2022
Q1
$11.3M Sell
218,364
-130,802
-37% -$6.79M 0.37% 52
2021
Q4
$20.6M Sell
349,166
-475
-0.1% -$23.5K 0.59% 22
2021
Q3
$15M Buy
349,641
+15,223
+5% +$674K 0.48% 37
2021
Q2
$13.1M Buy
334,418
+93,382
+39% +$3.63M 0.42% 41
2021
Q1
$8.74M Buy
241,036
+77,592
+47% +$2.75M 0.31% 64
2020
Q4
$6.02M Sell
163,444
-26,570
-14% -$975K 0.32% 71
2020
Q3
$6.49M Buy
190,014
+54,716
+40% +$1.92M 0.35% 69
2020
Q2
$4.2M Buy
135,298
+1,672
+1% +$56.8K 0.28% 90
2020
Q1
$4.14M Sell
133,626
-11,830
-8% -$403K 0.35% 65
2019
Q4
$5.41M Buy
145,456
+9,613
+7% +$342K 0.46% 47
2019
Q3
$4.63M Buy
135,843
+28,464
+27% +$1.04M 0.46% 42
2019
Q2
$4.42M Buy
107,379
+16,356
+18% +$649K 0.48% 40
2019
Q1
$3.67M Sell
91,023
-301
-0.3% -$12.1K 0.46% 51
2018
Q4
$3.79M Buy
91,324
+1,093
+1% +$45.4K 0.54% 39
2018
Q3
$3.77M Buy
90,231
+5,929
+7% +$228K 0.45% 53
2018
Q2
$2.9M Buy
84,302
+2,294
+3% +$78.4K 0.38% 59
2018
Q1
$2.76M Sell
82,008
-33,384
-29% -$1.15M 0.39% 62
2017
Q4
$3.97M Buy
115,392
+228
+0.2% +$7.77K 0.54% 39
2017
Q3
$3.9M Buy
115,164
+1,184
+1% +$38.1K 0.65% 34
2017
Q2
$3.63M Sell
113,980
-6,436
-5% -$203K 0.66% 29
2017
Q1
$3.91M Buy
120,416
+824
+0.7% +$26K 0.78% 25
2016
Q4
$3.69M Sell
119,592
-8,716
-7% -$266K 0.75% 29
2016
Q3
$3.22M Sell
128,308
-13,415
-9% -$449K 0.63% 27
2016
Q2
$3.78M Sell
141,723
-23,728
-14% -$757K 0.76% 21
2016
Q1
$4.03M Buy
165,451
+37,314
+29% +$1.07M 0.93% 15
2015
Q4
$3.92M Buy
128,137
+15,182
+13% +$478K 0.79% 20
2015
Q3
$3.37M Buy
112,955
+16,330
+17% +$524K 0.81% 17
2015
Q2
$3.08M Sell
96,625
-10,304
-10% -$336K 0.77% 19
2015
Q1
$3.53M Sell
106,929
-62,871
-37% -$2M 0.86% 13
2014
Q4
$27.6K Buy
169,800
+74,516
+78% +$2.14M 0.59% 19
2014
Q3
$2.67M Sell
95,284
-77,400
-45% -$2.17M 0.7% 23
2014
Q2
$2.58M Buy
172,684
+97,459
+130% +$2.78M 0.61% 21
2014
Q1
$2.29M Buy
75,225
+534
+0.7% +$15.9K 0.69% 25
2013
Q4
$2.17M Sell
74,691
-5,113
-6% -$149K 0.69% 25
2013
Q3
$2.17M Buy
79,804
+1,289
+2% +$35.1K 0.74% 19
2013
Q2
$2.09M Buy
+78,515
New +$2.17M 0.71% 22

Other funds holding PFE

B. Riley Wealth Advisors's PFE Position: Q2 2026 in Review

B. Riley Wealth Advisors reduced its Pfizer (PFE) stake by 7.7% in Q2 2026, selling an estimated $199K and leaving 90,498 shares worth $2.21M. The position accounts for 0.12% of the portfolio, ranked #169.

B. Riley Wealth Advisors first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $20.6M in Q4 2021. 720 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • B. Riley Wealth Advisors held 90,498 shares of Pfizer worth $2.21M as of Q2 2026.
  • B. Riley Wealth Advisors sold 7,592 Pfizer shares in Q2 2026, an estimated $199K.
  • Pfizer made up 0.12% of B. Riley Wealth Advisors's portfolio in Q2 2026, its #169 holding.
  • B. Riley Wealth Advisors first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • B. Riley Wealth Advisors's Pfizer position peaked at $20.6M in Q4 2021.
  • 720 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on B. Riley Wealth Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.